子宮頸がん検査の世界市場 2021年:メーカー別、地域別、種類・用途別

【英語タイトル】Global Cervical Cancer Test Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが出版した調査資料(GIR21AR03026)・商品コード:GIR21AR03026
・発行会社(調査会社):GlobalInfoResearch
・発行日:2021年4月
・ページ数:109
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2~3日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥382,800見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥574,200見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥765,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
GlobalInfoResearch社の本調査レポートでは、子宮頸がん検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。子宮頸がん検査の種類別市場規模(パパニコロウ塗抹検査、HPV DNA検査、VIA検査)、用途別市場規模(病院、研究所、医師オフィス・診療所)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Hologic、Qiagen N.V.、Becton, Dickinson and Company、Hoffman-La Roche、Abbott Molecular、Arbor Vita Corporation、OncoHealth Corporation、Dell Guided Therapeutics, Inc.、CooperSurgical, Inc.
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:パパニコロウ塗抹検査、HPV DNA検査、VIA検査
・用途別分析2016年-2026年:病院、研究所、医師オフィス・診療所
・子宮頸がん検査の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・子宮頸がん検査のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・子宮頸がん検査のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・子宮頸がん検査の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・子宮頸がん検査の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Cervical Cancer Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Cervical Cancer Test size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Cervical Cancer Test market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Cervical Cancer Test market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Pap Smear Test
HPV DNA Test
VIA Test

Market segment by Application, can be divided into
Hospitals
Laboratories
Physicians’ Offices & Clinics

Market segment by players, this report covers
Hologic
Qiagen N.V.
Becton, Dickinson and Company
Hoffman-La Roche
Abbott Molecular
Arbor Vita Corporation
OncoHealth Corporation
Dell Guided Therapeutics, Inc.
CooperSurgical, Inc.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Cervical Cancer Test
1.2 Classification of Cervical Cancer Test by Type
1.2.1 Overview: Global Cervical Cancer Test Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cervical Cancer Test Revenue Market Share by Type in 2020
1.2.3 Pap Smear Test
1.2.4 HPV DNA Test
1.2.5 VIA Test
1.3 Global Cervical Cancer Test Market by Application
1.3.1 Overview: Global Cervical Cancer Test Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Physicians’ Offices & Clinics
1.4 Global Cervical Cancer Test Market Size & Forecast
1.5 Global Cervical Cancer Test Market Size and Forecast by Region
1.5.1 Global Cervical Cancer Test Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cervical Cancer Test Market Size by Region, (2016-2021)
1.5.3 North America Cervical Cancer Test Market Size and Prospect (2016-2026)
1.5.4 Europe Cervical Cancer Test Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cervical Cancer Test Market Size and Prospect (2016-2026)
1.5.6 South America Cervical Cancer Test Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cervical Cancer Test Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cervical Cancer Test Market Drivers
1.6.2 Cervical Cancer Test Market Restraints
1.6.3 Cervical Cancer Test Trends Analysis
2 Company Profiles
2.1 Hologic
2.1.1 Hologic Details
2.1.2 Hologic Major Business
2.1.3 Hologic Cervical Cancer Test Product and Solutions
2.1.4 Hologic Cervical Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Hologic Recent Developments and Future Plans
2.2 Qiagen N.V.
2.2.1 Qiagen N.V. Details
2.2.2 Qiagen N.V. Major Business
2.2.3 Qiagen N.V. Cervical Cancer Test Product and Solutions
2.2.4 Qiagen N.V. Cervical Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Qiagen N.V. Recent Developments and Future Plans
2.3 Becton, Dickinson and Company
2.3.1 Becton, Dickinson and Company Details
2.3.2 Becton, Dickinson and Company Major Business
2.3.3 Becton, Dickinson and Company Cervical Cancer Test Product and Solutions
2.3.4 Becton, Dickinson and Company Cervical Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Becton, Dickinson and Company Recent Developments and Future Plans
2.4 Hoffman-La Roche
2.4.1 Hoffman-La Roche Details
2.4.2 Hoffman-La Roche Major Business
2.4.3 Hoffman-La Roche Cervical Cancer Test Product and Solutions
2.4.4 Hoffman-La Roche Cervical Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Hoffman-La Roche Recent Developments and Future Plans
2.5 Abbott Molecular
2.5.1 Abbott Molecular Details
2.5.2 Abbott Molecular Major Business
2.5.3 Abbott Molecular Cervical Cancer Test Product and Solutions
2.5.4 Abbott Molecular Cervical Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Abbott Molecular Recent Developments and Future Plans
2.6 Arbor Vita Corporation
2.6.1 Arbor Vita Corporation Details
2.6.2 Arbor Vita Corporation Major Business
2.6.3 Arbor Vita Corporation Cervical Cancer Test Product and Solutions
2.6.4 Arbor Vita Corporation Cervical Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Arbor Vita Corporation Recent Developments and Future Plans
2.7 OncoHealth Corporation
2.7.1 OncoHealth Corporation Details
2.7.2 OncoHealth Corporation Major Business
2.7.3 OncoHealth Corporation Cervical Cancer Test Product and Solutions
2.7.4 OncoHealth Corporation Cervical Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 OncoHealth Corporation Recent Developments and Future Plans
2.8 Dell Guided Therapeutics, Inc.
2.8.1 Dell Guided Therapeutics, Inc. Details
2.8.2 Dell Guided Therapeutics, Inc. Major Business
2.8.3 Dell Guided Therapeutics, Inc. Cervical Cancer Test Product and Solutions
2.8.4 Dell Guided Therapeutics, Inc. Cervical Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Dell Guided Therapeutics, Inc. Recent Developments and Future Plans
2.9 CooperSurgical, Inc.
2.9.1 CooperSurgical, Inc. Details
2.9.2 CooperSurgical, Inc. Major Business
2.9.3 CooperSurgical, Inc. Cervical Cancer Test Product and Solutions
2.9.4 CooperSurgical, Inc. Cervical Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 CooperSurgical, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cervical Cancer Test Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Cervical Cancer Test Players Market Share
3.2.2 Top 10 Cervical Cancer Test Players Market Share
3.2.3 Market Competition Trend
3.3 Cervical Cancer Test Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cervical Cancer Test Revenue and Market Share by Type (2016-2021)
4.2 Global Cervical Cancer Test Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cervical Cancer Test Revenue Market Share by Application (2016-2021)
5.2 Cervical Cancer Test Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cervical Cancer Test Revenue by Type (2016-2026)
6.2 North America Cervical Cancer Test Revenue by Application (2016-2026)
6.3 North America Cervical Cancer Test Market Size by Country
6.3.1 North America Cervical Cancer Test Revenue by Country (2016-2026)
6.3.2 United States Cervical Cancer Test Market Size and Forecast (2016-2026)
6.3.3 Canada Cervical Cancer Test Market Size and Forecast (2016-2026)
6.3.4 Mexico Cervical Cancer Test Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cervical Cancer Test Revenue by Type (2016-2026)
7.2 Europe Cervical Cancer Test Revenue by Application (2016-2026)
7.3 Europe Cervical Cancer Test Market Size by Country
7.3.1 Europe Cervical Cancer Test Revenue by Country (2016-2026)
7.3.2 Germany Cervical Cancer Test Market Size and Forecast (2016-2026)
7.3.3 France Cervical Cancer Test Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cervical Cancer Test Market Size and Forecast (2016-2026)
7.3.5 Russia Cervical Cancer Test Market Size and Forecast (2016-2026)
7.3.6 Italy Cervical Cancer Test Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cervical Cancer Test Revenue by Type (2016-2026)
8.2 Asia-Pacific Cervical Cancer Test Revenue by Application (2016-2026)
8.3 Asia-Pacific Cervical Cancer Test Market Size by Region
8.3.1 Asia-Pacific Cervical Cancer Test Revenue by Region (2016-2026)
8.3.2 China Cervical Cancer Test Market Size and Forecast (2016-2026)
8.3.3 Japan Cervical Cancer Test Market Size and Forecast (2016-2026)
8.3.4 South Korea Cervical Cancer Test Market Size and Forecast (2016-2026)
8.3.5 India Cervical Cancer Test Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cervical Cancer Test Market Size and Forecast (2016-2026)
8.3.7 Australia Cervical Cancer Test Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cervical Cancer Test Revenue by Type (2016-2026)
9.2 South America Cervical Cancer Test Revenue by Application (2016-2026)
9.3 South America Cervical Cancer Test Market Size by Country
9.3.1 South America Cervical Cancer Test Revenue by Country (2016-2026)
9.3.2 Brazil Cervical Cancer Test Market Size and Forecast (2016-2026)
9.3.3 Argentina Cervical Cancer Test Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cervical Cancer Test Revenue by Type (2016-2026)
10.2 Middle East & Africa Cervical Cancer Test Revenue by Application (2016-2026)
10.3 Middle East & Africa Cervical Cancer Test Market Size by Country
10.3.1 Middle East & Africa Cervical Cancer Test Revenue by Country (2016-2026)
10.3.2 Turkey Cervical Cancer Test Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cervical Cancer Test Market Size and Forecast (2016-2026)
10.3.4 UAE Cervical Cancer Test Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Cervical Cancer Test Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cervical Cancer Test Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cervical Cancer Test Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cervical Cancer Test Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cervical Cancer Test Revenue Market Share by Region (2021-2026)
Table 6. Hologic Corporate Information, Head Office, and Major Competitors
Table 7. Hologic Major Business
Table 8. Hologic Cervical Cancer Test Product and Solutions
Table 9. Hologic Cervical Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Qiagen N.V. Corporate Information, Head Office, and Major Competitors
Table 11. Qiagen N.V. Major Business
Table 12. Qiagen N.V. Cervical Cancer Test Product and Solutions
Table 13. Qiagen N.V. Cervical Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Becton, Dickinson and Company Corporate Information, Head Office, and Major Competitors
Table 15. Becton, Dickinson and Company Major Business
Table 16. Becton, Dickinson and Company Cervical Cancer Test Product and Solutions
Table 17. Becton, Dickinson and Company Cervical Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Hoffman-La Roche Corporate Information, Head Office, and Major Competitors
Table 19. Hoffman-La Roche Major Business
Table 20. Hoffman-La Roche Cervical Cancer Test Product and Solutions
Table 21. Hoffman-La Roche Cervical Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Abbott Molecular Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Molecular Major Business
Table 24. Abbott Molecular Cervical Cancer Test Product and Solutions
Table 25. Abbott Molecular Cervical Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Arbor Vita Corporation Corporate Information, Head Office, and Major Competitors
Table 27. Arbor Vita Corporation Major Business
Table 28. Arbor Vita Corporation Cervical Cancer Test Product and Solutions
Table 29. Arbor Vita Corporation Cervical Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. OncoHealth Corporation Corporate Information, Head Office, and Major Competitors
Table 31. OncoHealth Corporation Major Business
Table 32. OncoHealth Corporation Cervical Cancer Test Product and Solutions
Table 33. OncoHealth Corporation Cervical Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Dell Guided Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Dell Guided Therapeutics, Inc. Major Business
Table 36. Dell Guided Therapeutics, Inc. Cervical Cancer Test Product and Solutions
Table 37. Dell Guided Therapeutics, Inc. Cervical Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. CooperSurgical, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. CooperSurgical, Inc. Major Business
Table 40. CooperSurgical, Inc. Cervical Cancer Test Product and Solutions
Table 41. CooperSurgical, Inc. Cervical Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Cervical Cancer Test Revenue (USD Million) by Players (2019-2021)
Table 43. Global Cervical Cancer Test Revenue Share by Players (2019-2021)
Table 44. Breakdown of Cervical Cancer Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Cervical Cancer Test Players Head Office, Products and Services Provided
Table 46. Cervical Cancer Test Mergers & Acquisitions in the Past Five Years
Table 47. Cervical Cancer Test New Entrants and Expansion Plans
Table 48. Global Cervical Cancer Test Revenue (USD Million) by Type (2016-2021)
Table 49. Global Cervical Cancer Test Revenue Share by Type (2016-2021)
Table 50. Global Cervical Cancer Test Revenue Forecast by Type (2021-2026)
Table 51. Global Cervical Cancer Test Revenue by Application (2016-2021)
Table 52. Global Cervical Cancer Test Revenue Forecast by Application (2021-2026)
Table 53. North America Cervical Cancer Test Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Cervical Cancer Test Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Cervical Cancer Test Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Cervical Cancer Test Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Cervical Cancer Test Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Cervical Cancer Test Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Cervical Cancer Test Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Cervical Cancer Test Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Cervical Cancer Test Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Cervical Cancer Test Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Cervical Cancer Test Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Cervical Cancer Test Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Cervical Cancer Test Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Cervical Cancer Test Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Cervical Cancer Test Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Cervical Cancer Test Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Cervical Cancer Test Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Cervical Cancer Test Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Cervical Cancer Test Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Cervical Cancer Test Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Cervical Cancer Test Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Cervical Cancer Test Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Cervical Cancer Test Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Cervical Cancer Test Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Cervical Cancer Test Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Cervical Cancer Test Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Cervical Cancer Test Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Cervical Cancer Test Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Cervical Cancer Test Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Cervical Cancer Test Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cervical Cancer Test Picture
Figure 2. Global Cervical Cancer Test Revenue Market Share by Type in 2020
Figure 3. Pap Smear Test
Figure 4. HPV DNA Test
Figure 5. VIA Test
Figure 6. Cervical Cancer Test Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Laboratories Picture
Figure 9. Physicians’ Offices & Clinics Picture
Figure 10. Global Cervical Cancer Test Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Cervical Cancer Test Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Cervical Cancer Test Revenue Market Share by Region (2016-2026)
Figure 13. Global Cervical Cancer Test Revenue Market Share by Region in 2020
Figure 14. North America Cervical Cancer Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Cervical Cancer Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Cervical Cancer Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Cervical Cancer Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Cervical Cancer Test Market Drivers
Figure 19. Cervical Cancer Test Market Restraints
Figure 20. Cervical Cancer Test Market Trends
Figure 21. Hologic Recent Developments and Future Plans
Figure 22. Qiagen N.V. Recent Developments and Future Plans
Figure 23. Becton, Dickinson and Company Recent Developments and Future Plans
Figure 24. Hoffman-La Roche Recent Developments and Future Plans
Figure 25. Abbott Molecular Recent Developments and Future Plans
Figure 26. Arbor Vita Corporation Recent Developments and Future Plans
Figure 27. OncoHealth Corporation Recent Developments and Future Plans
Figure 28. Dell Guided Therapeutics, Inc. Recent Developments and Future Plans
Figure 29. CooperSurgical, Inc. Recent Developments and Future Plans
Figure 31. Global Cervical Cancer Test Revenue Share by Players in 2020
Figure 32. Cervical Cancer Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Cervical Cancer Test Revenue Market Share in 2020
Figure 34. Global Top 10 Players Cervical Cancer Test Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Cervical Cancer Test Revenue Share by Type in 2020
Figure 37. Global Cervical Cancer Test Market Share Forecast by Type (2021-2026)
Figure 38. Global Cervical Cancer Test Revenue Share by Application in 2020
Figure 39. Global Cervical Cancer Test Market Share Forecast by Application (2021-2026)
Figure 40. North America Cervical Cancer Test Sales Market Share by Type (2016-2026)
Figure 41. North America Cervical Cancer Test Sales Market Share by Application (2016-2026)
Figure 42. North America Cervical Cancer Test Revenue Market Share by Country (2016-2026)
Figure 43. United States Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Cervical Cancer Test Sales Market Share by Type (2016-2026)
Figure 47. Europe Cervical Cancer Test Sales Market Share by Application (2016-2026)
Figure 48. Europe Cervical Cancer Test Revenue Market Share by Country (2016-2026)
Figure 49. Germany Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Cervical Cancer Test Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Cervical Cancer Test Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Cervical Cancer Test Revenue Market Share by Region (2016-2026)
Figure 57. China Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Cervical Cancer Test Sales Market Share by Type (2016-2026)
Figure 64. South America Cervical Cancer Test Sales Market Share by Application (2016-2026)
Figure 65. South America Cervical Cancer Test Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Cervical Cancer Test Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Cervical Cancer Test Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Cervical Cancer Test Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Cervical Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source


【掲載企業】

Hologic、Qiagen N.V.、Becton, Dickinson and Company、Hoffman-La Roche、Abbott Molecular、Arbor Vita Corporation、OncoHealth Corporation、Dell Guided Therapeutics, Inc.、CooperSurgical, Inc.

★調査レポート[子宮頸がん検査の世界市場 2021年:メーカー別、地域別、種類・用途別] (コード:GIR21AR03026)販売に関する免責事項を必ずご確認ください。
★調査レポート[子宮頸がん検査の世界市場 2021年:メーカー別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆